National procurement with the expansion of the official launch: the scope of procurement is still the first 25 varieties
The expansion of national procurement with quantity officially started. September 1, Shanghai Sunshine Pharmaceutical Procurement Network announced the "Alliance Area Drug Centralized Procurement Document", which shows that this collection expansion will be pushed in 25 areas such as Shanxi, Inner Mongolia, Liaoning, Jilin, Heilongjiang, Jiangsu and Zhejiang, with the exception of 4+7 cities in the Alliance area. Involving the first batch of pilot atorvastatin oral normal release dosage form and other 25 winning varieties.
Unlike the first batch of pilot drug varieties where only one drug company won the bid, this time the same variety can be multiple winning bids, and the corresponding procurement volume also varies. The document shows that the actual selected enterprise is 1, the agreed procurement volume for the first year agreed procurement volume of 50% of the base calculation; the actual selected enterprise is 2, the agreed procurement volume for the first year agreed procurement volume of 60% of the base calculation; the actual selected enterprise is 3, the agreed procurement volume for the first year agreed procurement volume of 70% of the base calculation.
2026-09-01
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
MENA Pharmaceutical Regulatory Updates 2026: Key Compliance Changes for Global Pharma Companies
-
Biocytogen announces the launch of the 'Nano 100 Project' to develop fully human therapeutic nanobodies against 100+ targets
-
Wantai Biotech 20-valent pneumonia vaccine started clinical trials, how far is domestic substitution?
-
Yiming Cell 'Suspension 293XS Cell Bank' completed DMF filing with the US FDA
-
The phase III clinical study of Junshi Biologics in combination with teripulimab in the treatment of advanced triple-negative breast cancer reached the primary endpoint
-
The next bombshell: 'PD-1 + ADC', Kelun, Hengrui are going to win numbness?
-
L-Rotator Biotech completed its pre-A financing and continued to increase its investment in the CGT field
-
Hainan to promote drug import facilitation
-
Enable the 'export of EU APIcertification documents' and 'pharmaceutical export salescertificate' electronic proof
-
China to focus on building quality and efficient TCM service system in next five years
Recommend Reading
-
关于将二氟乙咪酯等16种物质列入《非药用类麻醉药品和精神药品目录》的公告 Announcement on the Inclusion of 16 Substances including Difluoroetomidate in the Catalogue of Non-Medicinal Narcotic Drugs and Psychotropic Substances
-
Four Fine Chemical Units of Huajin Aramco Project – HDPE, EO/EG, etc. – Reach Mechanical Completion
-
Pesticide Market in Limbo: Prices Plunge Amid Weak Demand and Overcapacity—Only a Few Hold Firm
-
关于将4-amino-1-boc-piperidine、tert-buty 4-aminopiperidine-1-carboxylate产品列入《ECHEMI平台禁限售商品目录》的公告 Announcement on Including 4-amino-1-boc-piperidine and tert-buty 4-aminopiperidine-1-carboxylate in the Announcement on the List of Prohibited Sales of Prohibited and Controlled Items on ECHEMI
-
FDA’s Warning to Compounders Raises the Stakes for API and Excipient Suppliers
-
Business Society’s MTBE Market Outlook on August 17, 2026: Slightly Bearish Consolidation
-
Business Society’s Market Outlook for Fuel Oil 180CST on August 17, 2026: Volatile (Bullish Tendency)
-
BDO market trend continues to rise in China
-
This Week's Styrene Market Fluctuates and Declines (3.30-4.3)
-
MTBE Market Trends: First Rise, Then Fall
- Hot Searches
- does dayquil make u drowsy
- benzene and styrene prices
- price of ammonium nitrate fertilizer
- phenylpiracetam hydrazide buy
- glycerol mono stearate
- diamane
- isopropanol vs n propanol
- ethyl acetate price
- polypropylene price per ton nigeria 2026
- janoshik tirzepatide
- ldpe resin price asia 2025 english
- nickel sulfamate solution